Drug information for MACUGEN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INTRAVITREAL
EQ 0.3MG ACID/0.09ML
Prescription
(Reference Drug)
PEGAPTANIB SODIUM
pegaptanib
EYETECH INC
21756
2011-10-20 Label
2011-10-14 Letter
2006-03-23 Letter
2006-03-10 Label
2006-03-10 Label
2005-11-18 Letter
2005-11-18 Letter
2005-03-28 Review
2004-12-30 Letter
2004-12-30 Label
Drug Adverse Effects information for MACUGEN
Role code
Indications
Reaction
# Reports
PS
AGE-RELATED MACULAR DEGENERATION
BLOOD PRESSURE SYSTOLIC INCREASED
2
PS
AGE-RELATED MACULAR DEGENERATION
CEREBRAL INFARCTION
2
PS
AGE-RELATED MACULAR DEGENERATION
CHEST PAIN
2
PS
AGE-RELATED MACULAR DEGENERATION
DEATH
1
PS
AGE-RELATED MACULAR DEGENERATION
UNEVALUABLE EVENT
1
PS
AGE-RELATED MACULAR DEGENERATION
VISUAL ACUITY REDUCED
1
PS
AGE-RELATED MACULAR DEGENERATION
VITREOUS HAEMORRHAGE
1
PS
CHOROIDAL NEOVASCULARISATION
CEREBRAL INFARCTION
1
PS
MACULAR OEDEMA
GASTRITIS
1
PS
MACULAR OEDEMA
INTRAOCULAR PRESSURE INCREASED
2
PS
RETINAL VEIN OCCLUSION
DRUG INEFFECTIVE
1
PS
RETINAL VEIN OCCLUSION
DYSPHAGIA
1
PS
RETINAL VEIN OCCLUSION
HYPERTENSION
1
PS
RETINAL VEIN OCCLUSION
INJECTION SITE DISCHARGE
1
PS
RETINAL VEIN OCCLUSION
LOCAL SWELLING
1
PS
RETINAL VEIN OCCLUSION
OCULAR DISCOMFORT
1
Ads by Google